ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!JNJ Company Profile and Key Details
Johnson & Johnson
JNJ Stock Price Chart
Stock Price Today
Johnson & Johnson (JNJ) stock surged +1.64%, trading at $162.30 on NYSE, up from the previous close of $159.68. The stock opened at $159.88, fluctuating between $159.28 and $163.51 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Company Information
| Employees | 138100 |
| Beta | 0.51 |
| Sales or Revenue | $85.15B |
| 5Y Sales Change% | 0.097% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently Asked Questions
Johnson & Johnson (NYSE: JNJ) stock price is $162.30 in the last trading session. During the trading session, JNJ stock reached the peak price of $163.51 while $159.28 was the lowest point it dropped to. The percentage change in JNJ stock occurred in the recent session was 1.64% while the dollar amount for the price change in JNJ stock was $2.62.
The NYSE listed JNJ is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Johnson & Johnson designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Robert J. Decker Jr.
Controller & Chief Accounting Officer
Dr. Peter M. Fasolo Ph.D.
Executive Vice President & Chief HR Officer
Ms. Elizabeth Forminard
Executive Vice President & Gen. Counsel
Mr. Alex Gorsky
Executive Chairman
Dr. Guy J. Lebeau M.D.
Group Chairman of MD&D Bus. - EMEA
Mr. Joseph J. Wolk C.P.A.
Executive Vice President & Chief Financial Officer
Ms. Ashley A. McEvoy
Executive Vice President & Worldwide Chairman of MedTech
Mr. Thibaut Mongon
Chief Executive Officer & Director
Ms. Jennifer L. Taubert
Executive Vice President & Worldwide Chairman of Pharmaceuticals
Dr. John C. Reed M.D., Ph.D.
Executive Vice President of Pharmaceuticals R&D
Mr. Joseph J. Wolk CPA
Executive Vice President & Chief Financial Officer
Mr. Dirk Brinckman
Chief Compliance Officer
Mr. Joaquin Duato
Chief Executive Officer & Director
Mr. James Swanson
Executive Vice President & Chief Information Officer
Ms. Jessica Moore
Vice President of Investor Relations
JNJ's closing price is 15.37% higher than its 52-week low of $140.68 where as its distance from 52-week high of $168.85 is -3.88%.
Number of JNJ employees currently stands at 138,100.
Official Website of JNJ is: https://www.jnj.com
JNJ could be contacted at phone 732 524 0400 and can also be accessed through its website. JNJ operates from One Johnson & Johnson Plaza, New Brunswick, NJ 08933, United States.
JNJ stock volume for the day was 12.25M shares. The average number of JNJ shares traded daily for last 3 months was 8.71M.
The market value of JNJ currently stands at $390.76B with its latest stock price at $162.30 and 2.41B of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com